BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 12839698)

  • 21. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer.
    Yoshimatsu K; Yokomizo H; Fujimoto T; Umehara A; Otani T; Matsumoto A; Osawa G; Shiozawa S; Katsube T; Naritaka Y; Ogawa K
    Anticancer Res; 2007; 27(3B):1641-4. PubMed ID: 17595789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients].
    Xiong X; Zhu Z; Wen Z
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):411-3. PubMed ID: 11778280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers].
    Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Yao Y
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):749-52. PubMed ID: 15733397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study on patients with advanced gastric cancer treated with oxaliplatin combining with hydroxycamptothecine].
    Yang CX; Huang HX; Li GS
    Ai Zheng; 2002 Aug; 21(8):885-7. PubMed ID: 12478899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of S-1 maintenance chemotherapy following DCF regimen in patients with advanced gastric cancer].
    Chen J; Shen W; Xia J; Xu R; Zhu M; Xu M
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1057-60. PubMed ID: 25057084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multicentral Questionnaire Results for Consciousness of Medical Personnel on Chemotherapy for Gastric and Colorectal Cancer].
    Sasaki S; Hiraiwa T; Ishimaru M; Funahashi K; Koike J; Seto Y; Yamashita H; Furushima K; Sakai K
    Gan To Kagaku Ryoho; 2018 Aug; 45(8):1171-1176. PubMed ID: 30158413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    Mavani PT; Ajay PS; Goyal S; Shah MM
    J Surg Oncol; 2023 Dec; 128(8):1461-1463. PubMed ID: 37846210
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the survival of patients with cancer of the cardia].
    Nosek H; Leńczyk M
    Nowotwory; 1967; 17(3):285-8. PubMed ID: 6063293
    [No Abstract]   [Full Text] [Related]  

  • 30. [Water disorders in patients with advanced cancer of the cardia].
    Wieraszko-Burzyńska E; Lewiński T; Radom S; Nowosielski J
    Nowotwory; 1970; 20(1):13-21. PubMed ID: 5440882
    [No Abstract]   [Full Text] [Related]  

  • 31. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic drugs for gastric and colorectal cancer.
    Cunningham D
    BMJ; 1989 Dec; 299(6714):1479-80. PubMed ID: 2514857
    [No Abstract]   [Full Text] [Related]  

  • 34. [The evaluation of LFH or LFPH in the treatment of advanced cancer of gastric cardia and colorectal cancer].
    Zhang XD; Shen L; Li Y; Li J; Yang BQ; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):289-91. PubMed ID: 12839698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
    Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.